Microneedles at the Forefront of Next Generation Theranostics
Advanced Science · 2025-06 · 12 (24)
DOI: 10.1002/advs.202412140 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 30.01.2025. Verfasst von Chan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering (BME), National University of Singapore, Singapore, 117583, Singapore. Hauptthemen laut MEDLINE: Needles, Drug Delivery Systems, Theranostic Nanomedicine, Microinjections. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Agency for Science, Technology and Research, Wellcome Leap.
Abstract (Originalsprache)
Theranostics, combining therapeutic and diagnostic functions, marks a revolutionary advancement in modern medicine, with microneedle technology at its forefront. This review explores the substantial developments and multifaceted applications of microneedles, which have evolved from basic transdermal drug delivery devices to sophisticated diagnostic and therapeutic platforms. Microneedles enhance access to biomarkers via interstitial fluid, enabling real‐time monitoring of physiological conditions, such as glucose and hormone levels, thus facilitating continuous health tracking. The evolution of microneedle design from solid to dissolvable forms broadens their utility from mere drug delivery to complex sensing and therapeutic applications, including insulin delivery for diabetes management, vaccination, and gene therapy. This paper delves into the integration of microneedles with wearable technologies, highlighting their role in closed‐loop systems that combine real‐time monitoring with dynamic, precise therapeutic delivery. By addressing gaps in the literature regarding their integrated diagnostic and treatment capabilities, this review underscores the pivotal role of microneedles in personalizing medicine. It concludes with a visionary perspective on the future trajectory of microneedle technology, emphasizing its potential to revolutionize therapeutic strategies through enhanced efficacy, safety, and patient compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering (BME), National University of Singapore, Singapore, 117583, Singapore.
- Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore, 117599, Singapore.
- Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, 101400, China.
- State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
- Department of Radiology, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Road, Xicheng District, Beijing, 100050, China.
- School of Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, 100049, China.
ORCID-Profile: Pengfei Zhao
Förderung
- Wellcome Trust
- Agency for Science, Technology and Research
- Wellcome Leap
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Yang, Y., Zhang, J., Zhang, H., Wang, Q., Ma, S., Zhao, P., Li, Z., & Liu, Y. (2025). Microneedles at the Forefront of Next Generation Theranostics. Advanced Science, 12(24). https://doi.org/10.1002/advs.202412140
Vancouver
Wang C, Yang Y, Zhang J, Zhang H, Wang Q, Ma S, et al. Microneedles at the Forefront of Next Generation Theranostics. Advanced Science. 2025;12(24). doi:10.1002/advs.202412140
BibTeX
@article{Wang2025,
author = {Wang, Chan and Yang, Yuan and Zhang, Jiaqi and Zhang, Hanrui and Wang, Qian and Ma, Shengmei and Zhao, Pengfei and Li, Zhou and Liu, Yuxin},
title = {Microneedles at the Forefront of Next Generation Theranostics},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {24},
doi = {10.1002/advs.202412140}
}
EUVIMED